Arlington, Texas
United States
49
2019-01-31
The entities that hold a legal rights for patent applications filed by inventor Gamache Daniel A.:
Daniel A. Gamache from Arlington, US has applied for patents for these inventions. The list has both pending applications and granted patents:
RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#2 | 2017-03-16High Concentration Olopatadine Ophthalmic Composition
#3 | 2017-02-23RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders
#4 | 2016-12-22RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions
#5 | 2016-09-08RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS
#6 | 2016-02-25RNAi-mediated inhibition of histamine receptor H1-related conditions
#7 | 2014-12-04RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#8 | 2014-12-04RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#9 | 2014-10-02High concentration olopatadine ophthalmic composition
#10 | 2014-08-14Method of Accelerating Corneal Wound Healing
#11 | 2014-06-19RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
#12 | 2014-03-27RNAi-mediated inhibition of histamine receptor H1-related conditions
#13 | 2014-03-18RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders
#14 | 2013-12-19RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS
#15 | 2013-02-21BICYCLIC HETEROARYL INHIBITORS OF PDE4
#16 | 2012-11-22High concentration olopatadine ophthalmic composition
#17 | 2012-10-18RNAi-mediated inhibition of histamine receptor H1-related conditions
#18 | 2012-03-15HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
#19 | 2012-01-19METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALLERGY
#20 | 2011-11-24RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#21 | 2011-11-03RNAi-mediated inhibition of histamine receptor H1-related conditions
#22 | 2011-08-25METHOD OF ACCELERATING CORNEAL WOUND HEALING
#23 | 2011-06-16RNAi-mediated inhibition of tumor necrosis factor α-related conditions
#24 | 2011-06-02METHOD OF TREATING DRY EYE DISORDERS AND UVEITIS
#25 | 2010-05-13HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
#26 | 2010-04-01Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
#27 | 2010-03-11AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
#28 | 2009-12-31RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
#29 | 2009-11-05RNAi-mediated inhibition of histamine receptor H1-related conditions
#30 | 2009-07-16USE OF A COMBINATION OF OLOPATADINE AND CILOMILAST TO TREAT NON-INFECTIOUS RHINITIS AND ALLERGIC CONJUNCTIVITIS
#31 | 2009-05-21USE OF TRPV1 RECEPTOR ANTAGONISTS FOR TREATING DRY EYE AND OCULAR PAIN
#32 | 2009-04-16USE OF TNF RECEPTOR ANTAGONISTS FOR TREATING DRY EYE
#33 | 2008-10-16Use of an Inhibitor of TNFa Plus an Antihistamine to Treat Allergic Rhinitis and Allergic Conjunctivitis
#34 | 2008-06-12USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR
#35 | 2008-04-24USE OF OCULOSURFACE SELECTIVE GLUCOCORTICOID IN THE TREATMENT OF DRY EYE
#36 | 2007-12-06RNAI-mediated inhibition of tumor necrosis factor α-related conditions
#37 | 2006-09-28Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells
#38 | 2006-08-24Methods of treating dry eye disorders
#39 | 2006-06-15Method of treating dry eye disorders using 13(S)-HODE and its analogs
#40 | 2006-05-115,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses
#41 | 2006-04-11Methods of treating dry eye disorders
#42 | 2006-03-30Methods for treating dry eye
#43 | 2006-03-16Method of treating dry eye disorders and uveitis
#44 | 2006-03-16Use of oculosurface selective glucocorticoid in the treatment of dry eye
#45 | 2006-01-19Use of pde iv inhibitors to treat angiogenesis
#46 | 2005-12-15Use of PDE IV inhibitors to treat angiogenesis
#47 | 2005-11-17Method of treating dry eye disorders and uveitis
#48 | 2005-06-30Method of treating vascular endothelial growth factor mediated vascular disorders
#49 | 2005-03-29Use of selective PDE IV inhibitors to treat dry eye disorders
102166 ⎘